%20(1).svg)
.png)
Drug Development & Delivery Magazine - Special Feature
SPECIAL FEATURE – Solubility & Bioavailability: Utilizing Enabling Technologies
Contributor Cindy H. Dubin interviews Serán and several other leading companies, on how they are using innovative technologies to improve bioavailability challenges.
Serán’s CEO, Dan Smithey, PhD, discusses the use of technology as the key enabler for overcoming molecules exhibiting low bioavailability. As molecules become more complex, so does the need to innovate and develop new technologies to resolve problems. “In addition to particle engineering, the development of solid dosage form is key to successfully improving bioavailability,” says Dr. Smithey.
Read on to learn more about Serán’s science-first, technology driven focus on turning complex molecules into medicines.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
.svg)